drug

bivalirudin

Marketedupdated 2mo ago

by Avenacy Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 36m ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Jul 27, 2028

~2.0 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (8)

May 20, 2039method-of-use (U-3817)US 11903993
May 20, 2039method-of-use (U-3817)US 11918622
May 20, 2039formulationUS 11992514
May 20, 2039formulationUS 12472224
Jan 27, 2029patentUS 7582727*PED2.6y
Jan 27, 2029patentUS 7598343*PED2.6y
Jul 27, 2028formulationUS 75827272.0y
Jul 27, 2028formulationUS 75983432.0y